ConductScience.org, home

Paper10690882

Alendronate and estrogen effects in postmenopausal women with low bone mineral density. Alendronate/Estrogen Study Group.

Bone HG and 16 others. J Clin Endocrinol Metab, 2000. Cited by 202 papers, by iCite.

Cite this record

ConductScience Library. Alendronate and estrogen effects in postmenopausal women with low bone mineral density. Alendronate/Estrogen Study Group. Papers, record 10690882. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/10690882

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Alendronate and estrogen effects in postmenopausal women with low bone mineral density. Alendronate/Estrogen Study Group.
PubMed
Journal
J Clin Endocrinol Metab
PubMed
Year
2000
PubMed
Publication types
Clinical Trial, Journal Article, Multicenter Study, Randomized Controlled Trial, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
202
iCite
Relative citation ratio, by iCite
6.24
iCite
Revised in PubMed
2013-11-21
PubMed

Authors17

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Bone HGH G
2Greenspan SLS L
3McKeever CC
4Bell NN
5Davidson MM
6Downs RWR W
7Emkey RR
8Meunier PJP J
9Miller SSS S
10Mulloy ALA L
11Recker RRR R
12Weiss SRS R
13Heyden NN
14Musliner TT
15Suryawanshi SS
16Yates AJA J
17Lombardi AA

Source PubMed

Download CSV of authors

Topics16

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
AlendronateMajor topic
Bone DensityMajor topic
Estrogens, Conjugated (USP)Major topic
PostmenopauseMajor topic
Adult
Aged
Animals
Biopsy
Bone Remodeling
Bone and Bones
Double-Blind Method
Drug Therapy, Combination
Female
Horses
Humans
Middle Aged

Source PubMed

Download CSV of topics

Cited by59

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 202 citations.

PMIDTitleJournalYearIn PapersSource
39868546Alendronate for the primary and secondary prevention of osteoporotic fractures in postmenopausal women.Cochrane Database Syst Rev2025https://conductscience.org/library/papers/39868546PubMed
39585849Advantages of statin usage in preventing fractures for men over 50 in the United States: National Health and Nutrition Examination Survey.PLoS One2024https://conductscience.org/library/papers/39585849PubMed
39566720Effect of donepezil on bone metabolism among older adults with Alzheimer's disease.Contemp Clin Trials2025https://conductscience.org/library/papers/39566720PubMed
39530312Pilot study of the effect of surgical menopause on bone mineral density and quality in patients with gynecological malignancies.J Obstet Gynaecol Res2025https://conductscience.org/library/papers/39530312PubMed
39315499The 2024 Guidelines for Osteoporosis - Korean Society of Menopause: Part II.J Menopausal Med2024https://conductscience.org/library/papers/39315499PubMed
39031177Severe atypical iliac wing fracture associated with long-term bisphosphonate use.Skeletal Radiol2025https://conductscience.org/library/papers/39031177PubMed
38477744Differences in bone histomorphometry between White postmenopausal women with and without atypical femoral fracture after long-term bisphosphonate therapy.J Bone Miner Res2024https://conductscience.org/library/papers/38477744PubMed
37130601
Fracture risk reduction and safety by osteoporosis treatment compared with placebo or active comparator in postmenopausal women: systematic review, network meta-analysis, and meta-regression analysis of randomised clinical trials.
BMJ2023https://conductscience.org/library/papers/37130601PubMed
36837459The Impact of Progesterone and Estrogen on the Tooth Mobility.Medicina (Kaunas)2023https://conductscience.org/library/papers/36837459PubMed
34831656Association between Osteoporosis and Previous Statin Use: A Nested Case-Control Study.Int J Environ Res Public Health2021https://conductscience.org/library/papers/34831656PubMed
34724173The Effects of Osteoporotic and Non-osteoporotic Medications on Fracture Risk and Bone Mineral Density.Drugs2021https://conductscience.org/library/papers/34724173PubMed
34660852Dose-dependent effects of pharmaceutical treatments on bone matrix properties in ovariectomized rats.Bone Rep2021https://conductscience.org/library/papers/34660852PubMed
34531991Association of bone mineral density and depression in different bone sites and ages: A meta-analysis.Food Sci Nutr2021https://conductscience.org/library/papers/34531991PubMed
33240217Oral Treatment With Bisphosphonates of Osteoporosis Does Not Increase the Risk of Severe Gastrointestinal Side Effects: A Meta-Analysis of Randomized Controlled Trials.Front Endocrinol (Lausanne)2020https://conductscience.org/library/papers/33240217PubMed
32588816Denosumab, raloxifene, romosozumab and teriparatide to prevent osteoporotic fragility fractures: a systematic review and economic evaluation.Health Technol Assess2020https://conductscience.org/library/papers/32588816PubMed
31950363Combined antisclerostin antibody and parathyroid hormone (1-34) synergistically enhance the healing of bone defects in ovariectomized rats.Z Gerontol Geriatr2020https://conductscience.org/library/papers/31950363PubMed
31558481Diagnosis of osteoporosis in statin-treated patients is dose-dependent.Ann Rheum Dis2019https://conductscience.org/library/papers/31558481PubMed
31076895Local administration of aspirin with β-tricalcium phosphate/poly-lactic-co-glycolic acid (β-TCP/PLGA) could enhance osteoporotic bone regeneration.J Bone Miner Metab2019https://conductscience.org/library/papers/31076895PubMed
29392472Single-dose local administration of parathyroid hormone (1-34, PTH) with β-tricalcium phosphate/collagen (β-TCP/COL) enhances bone defect healing in ovariectomized rats.J Bone Miner Metab2019https://conductscience.org/library/papers/29392472PubMed
28667435Using Osteoporosis Therapies in Combination.Curr Osteoporos Rep2017https://conductscience.org/library/papers/28667435PubMed

See all 59 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/10690882

GET https://conductscience.org/api/papers/v1/10690882/cited_by?page=2